TPD

(redirected from Therapeutic Products Directorate)
Also found in: Acronyms, Wikipedia.

TPD

Abbreviation for:
temporary partial disability
Therapeutic Products Directorate (Canada)
threatened preterm delivery
tidal peritoneal dialysis
Training Programme Director, see there 
tropical pancreatic diabetes
two-point discrimination
Mentioned in ?
References in periodicals archive ?
Nephros is pleased to have received approval from the Therapeutic Products Directorate to market its Dual Stage Ultrafilters in Canada," said Dr.
NYSE:MDT), has received regulatory approval from Health Canada's Therapeutic Products Directorate (TPD) for use of the Endeavor drug-eluting coronary stent (DES) system in the treatment of coronary artery disease.
TSX: DDS; NASDAQ: DDSS) today announced it has filed a New Drug Submission (NDS) with the Therapeutic Products Directorate of Health Canada for its novel formulation of the antidepressant trazodone.
The features and benefits of Glumetza[TM] 1,000mg, which received a Notice of Compliance (NOC) from the Therapeutic Products Directorate (TPD) in October 2007, are being introduced to health-care professionals throughout the country by Biovail Pharmaceuticals Canada (BPC), the Company's Canadian sales and marketing division.
The Company reported that Health Canada's Therapeutic Products Directorate (TPD), the authority that regulates pharmaceutical drugs and medical devices, has approved its use.
The features and benefits of Ralivia[TM], which received a Notice of Compliance from the Therapeutic Products Directorate on August 31, are being introduced to health-care professionals throughout the country by Biovail Pharmaceuticals Canada, the Company's Canadian sales and marketing division.
TORONTO -- Biovail Corporation (NYSE:BVF)(TSX:BVF) today announced that the Therapeutic Products Directorate (TPD) Canada has issued a Notice of Compliance (NOC) for 100mg, 200mg and 300mg tablet strengths of Ralivia[TM], the Company's once-daily, extended-release formulation of tramadol hydrochloride indicated for the management of pain of moderate severity in patients who require continuous treatment for several days or more.
EntreMed received a No Objection Letter (NOL) from the Therapeutic Products Directorate of Health Canada on its Clinical Trial Application to conduct the clinical trial in leukemia patients.
Food and Drug Administration, Canadian Therapeutic Products Directorate and European regulatory approvals, acceptance and demand for new pharmaceutical products, the impact of competitive products and pricing, new product development and launch, reliance on key strategic alliances, availability of raw materials and finished products, the regulatory environment, tax rate assumptions, the outcome of legal proceedings, fluctuations in operating results and other risks detailed from time to time in the Company's filings with the Securities and Exchange Commission and the Ontario Securities Commission, as well as the Company's ability to anticipate and manage the risks associated with the foregoing.
TSX: PLB), Paladin has obtained approval from the Therapeutic Products Directorate (TPD) of Health Canada to market SEASONALE(R) Tablets, the first extended-cycle oral contraceptive available in Canada.
Food and Drug Administration and in June 2006 by Therapeutic Products Directorate of Health Canada for the treatment of women with metastatic breast cancer.
TSX: DDS; NASDAQ: DDSS) today announced that it has received a Notice of Compliance (NOC) from the Therapeutic Products Directorate (TPD) of Health Canada for 100 mg, 200 mg and 300 mg tablets of its once-daily formulation of tramadol for the management of pain of moderate severity in adults who require treatment for several days or more.

Full browser ?